Portugal Clinical Studies

Services

Provide support and advice in the preparation of contractual and other study documentation to ensure compliance with quality standards.

Feasibility

Allows the submission of support requests for country/site feasibility, analysed by a dedicated team.

Regulatory Affairs

Involves providing support in identifying applicable legislation and regulations for the study, as well as preparing responses to requests from regulatory authorities.

Contracting of Network Studies

Support the development and coordination of the collaboration protocol and the corresponding contract between CRSs when participants are referred for clinical research purposes.

Strategic Planning and Optimisation

Assist CRSs in developing a strategic vision, creating action plans, and enhancing operational efficiency to enable more effective resource allocation throughout clinical studies.

Data entry for Case Report Form (CRF)

It allows Data Entry outsourcing for recording clinical study data on the Case Report Form (CRF), ensuring the accuracy and integrity of the collected data.

Recruitment

Consists in the creation of a digital channel to promote clinical studies. It aims at facilitating the recruitment of participants.

Portugal in Numbers

4th POSITION

among 82 countries, in the number of health researchers per million inhabitants.

Source: Global Observatory on Health R&D (2022).

27th POSITION

among 140 economies worldwide, in the quality of research centers.

Source: The Global Competitiveness Report (2019).

421

Clinical trials initiated in 2024 in Portugal.

Source: 2024 indicators data

1347

Clinical studies initiated in 2024 in Portugal.

Source: 2024 indicators data

Driving excellence and generating impact in clinical research in Portugal

The IC&IB performance indicators represent a strategic milestone for the Clinical Research Sites (CRSs) within healthcare institutions. Developed with the aim of promoting operational efficiency, strengthening the national research network, and positioning Portugal as an international reference in the field of biomedical research, these indicators serve as an essential tool to enhance the quality and competitiveness of clinical research in the country.

Map of Clinical Trials launched in the EU

The Clinical Trials Information System (CTIS)️ launched an interactive map, on March 3 2025, designed to facilitate access to information about clinical trials in the European Union.

This map allows users to search for ongoing Clinical Trials by location and medical condition, as well as access investigator contact details to learn how to participate.

A specialised team, beyond Science

Portugal Clinical Studies® is a platform of the Agency for Clinical Research and Biomedical Innovation that brings together a dynamic and specialised team to help streamline and simplify the processes inherent to your clinical study.

Why Portugal?

Positioning Portugal among the most attractive countries for conducting clinical trials in the European Union is the vision adopted by the Portuguese government for the area of clinical research. Clinical studies represent one of the main strategic areas for the development of healthcare in Portugal.

Clinical Research Sites (CRSs)

Come and discover the entities conducting clinical studies at the national level.

The CRSs play a role in advacing comprehensive clinical research - from study development to professional training - fostering collaboration and excellence in the healthcare sector.

Patient Associations

National Network of Patient Associations: Together for Innovation in Health

The experience of patients is essential to turn clinical research into real solutions. Our national network brings together associations committed to accelerating scientific progress.

News

View all

Get to know the latest news in the field of Portuguese clinical studies.